Modulation of Pseudomonas aeruginosa surface-associated group behaviors by individual amino acids through c-di-GMP signaling

Research in Microbiology

Volumn 162, Issue 7, 2011, Pages 680-688

  Bernier, Steve P ^a   Ha, Dae Gon ^a   Khan, Wajiha ^a,b   Merritt, Judith H ^a,c   O'Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c Glycobia Inc   (United States)

Author keywords

Amino acids; Biofilm; C di GMP; Cystic fibrosis; Swarming

Indexed keywords

AMINO ACID; ARGININE; BACTERIAL PROTEIN; CYCLIC GMP; ISOLEUCINE; LEUCINE; ORNITHINE; PHENYLALANINE; ROEA PROTEIN; SADC PROTEIN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE MUTATION; GROUP DYNAMICS; IN VIVO STUDY; INTRACELLULAR FLUID; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

AMINO ACIDS; BACTERIAL PROTEINS; BIOFILMS; CYCLIC GMP; ESCHERICHIA COLI PROTEINS; PHOSPHORUS-OXYGEN LYASES; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION;

PSEUDOMONAS AERUGINOSA;

EID: 79960891629     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2011.04.014     Document Type: Article

References (31)

1. Alarcon R., Orellana M.S., Neira B., Uribe E., Garcia J.R., Carvajal N. Mutational analysis of substrate recognition by human arginase type I-agmatinase activity of the N130D variant. FEBS J. 2006, 273:5625-5631.
2. Alvarez-Ortega C., Harwood C.S. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 2007, 65:153-165.
3. Bertani G. Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J. Bacteriol. 2004, 186:595-600.
4. Brown S.A., Palmer K.L., Whiteley M. Revisiting the host as a growth medium. Nat. Rev. Microbiol. 2008, 6:657-666.
5. Caiazza N.C., O'Toole G.A. SadB is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA14. J. Bacteriol. 2004, 186:4476-4485.
6. Caiazza N.C., Merritt J.H., Brothers K.M., O'Toole G.A. Inverse regulation of biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 2007, 189:3603-3612.
7. Cegelski L., Marshall G.R., Eldridge G.R., Hultgren S.J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 2008, 6:17-27.
8. Eschbach M., Schreiber K., Trunk K., Buer J., Jahn D., Schobert M. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 2004, 186:4596-4604.
9. Grasemann C., Ratjen F., Schnabel D., Reutershahn E., Vester U., Grasemann H. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. Eur. Respir. J. 2008, 31:815-821.
10. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007, 153:917-923.
11. Kohler T., Curty L.K., Barja F., van Delden C., Pechere J.C. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 2000, 182:5990-5996.
12. Kuchma S.L., Brothers K.M., Merritt J.H., Liberati N.T., Ausubel F.M., O'Toole G.A. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 2007, 189:8165-8178.
13. LiPuma J.J. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 2010, 23:299-323.
14. Merritt J.H., Brothers K.M., Kuchma S.L., O'Toole G.A. SadC reciprocally influences biofilm formation and swarming motility via modulation of exopolysaccharide production and flagellar function. J. Bacteriol. 2007, 189:8154-8164.
15. Merritt J.H., Ha D.G., Cowles K.N., Lu W., Morales D.K., Rabinowitz J., Gitai Z., O'Toole G.A. Specific control of Pseudomonas aeruginosa surface-associated behaviors by two c-di-GMP diguanylate cyclases. MBio 2010, 1. pii: e00183-10.
16. Miller J.H. Experiments in Molecular Genetics 1972, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
17. O'Toole G.A. How Pseudomonas aeruginosa regulates surface behaviors. Microbe 2008, 3:65-71.
18. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 1998, 28:449-461.
19. Palmer K.L., Mashburn L.M., Singh P.K., Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 2005, 187:5267-5277.
20. Palmer K.L., Aye L.M., Whiteley M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 2007, 189:8079-8087.
21. Palmer G.C., Palmer K.L., Jorth P.A., Whiteley M. Characterization of the Pseudomonas aeruginosa transcriptional response to phenylalanine and tyrosine. J. Bacteriol. 2010, 192:2722-2728.
22. Rasko D.A., Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 2010, 9:117-128.
23. Schreiber K., Boes N., Eschbach M., Jaensch L., Wehland J., Bjarnsholt T., Givskov M., Hentzer M., Schobert M. Anaerobic survival of Pseudomonas aeruginosa by pyruvate fermentation requires an Usp-type stress protein. J. Bacteriol. 2006, 188:659-668.
24. Sibley C.D., Parkins M.D., Rabin H.R., Duan K., Norgaard J.C., Surette M.G. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15070-15075.
25. Sibley C.D., Parkins M.D., Rabin H.R., Surette M.G. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Curr. Opin. Invest. Drugs 2009, 10:787-794.
26. Talaue M.T., Venketaraman V., Hazbon M.H., Peteroy-Kelly M., Seth A., Colangeli R., Alland D., Connell N.D. Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection. J. Bacteriol. 2006, 188:4830-4840.
27. Toutain C.M., Zegans M.E., O'Toole G.A. Evidence for two flagellar stators and their role in the motility of Pseudomonas aeruginosa. J. Bacteriol. 2005, 187:771-777.
28. Tremblay J., Deziel E. Improving the reproducibility of Pseudomonas aeruginosa swarming motility assays. J. Basic Microbiol. 2008, 48:509-515.
29. Vander Wauven C., Pierard A., Kley-Raymann M., Haas D. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 1984, 160:928-934.
30. Wolfgang M.C., Jyot J., Goodman A.L., Ramphal R., Lory S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6664-6668.
31. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109:317-325.